Compare PRCH & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRCH | OSUR |
|---|---|---|
| Founded | 2012 | 2000 |
| Country | United States | United States |
| Employees | 803 | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 753.7M | 214.1M |
| IPO Year | 2019 | 2000 |
| Metric | PRCH | OSUR |
|---|---|---|
| Price | $7.54 | $3.07 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 2 |
| Target Price | ★ $17.11 | $3.00 |
| AVG Volume (30 Days) | ★ 1.2M | 518.1K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 90.91 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $482,414,000.00 | $167,064,000.00 |
| Revenue This Year | $3.86 | $4.48 |
| Revenue Next Year | $16.83 | $7.76 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.18 | N/A |
| 52 Week Low | $4.65 | $2.08 |
| 52 Week High | $19.44 | $3.76 |
| Indicator | PRCH | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 48.19 | 54.98 |
| Support Level | $6.36 | $3.05 |
| Resistance Level | $9.89 | $3.29 |
| Average True Range (ATR) | 0.41 | 0.18 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 38.72 | 42.54 |
Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has four reportable segments: Insurance Services, Software & Data, Consumer Services, and Corporate. The majority of revenue is from the Insurance segment. The Insurance Services segment manages and operates the Reciprocal, providing services related, but not limited, to underwriting, policy renewal, risk management, insurance portfolio management, financial management, and setting investment guidelines in exchange for commissions and fees.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.